AsiaPharm Group received an offer from private equity firm MBK Partners to take the company private for $253 million. MBK has been assured that stockholders holding 44% of the outstanding shares will vote in favor of the proposal. AsiaPharm is listed on the Singapore exchange, but its operations are in China. MBK, which manages $1.5 billion, is based in the Cayman Islands and focuses on Asia. We look at the deal.  More details...

Stock Symbol: (SI: ASPH)